Development and function of CD94-deficient natural killer cells

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Orr, Mark T ^a   Wu, Jun ^b   Fang, Min ^c   Sigal, Luis J ^c   Spee, Pieter ^d   Egebjerg, Thomas ^d   Dissen, Erik ^e   Fossum, Sigbjørn ^e   Phillips, Joseph H ^b   Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d NOVO NORDISK A S   (Denmark)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; LYMPHOCYTE RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2C; NATURAL KILLER CELL RECEPTOR NKG2E; UNCLASSIFIED DRUG; KLRC1 PROTEIN, MOUSE; KLRC2 PROTEIN, MOUSE; KLRD1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL MATURATION; CONTROLLED STUDY; CYTOLOGY; CYTOMEGALOVIRUS; GENE TARGETING; GENETIC ASSOCIATION; LISTERIA MONOCYTOGENES; LYMPHOCYTE FUNCTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; TARGET CELL; TRANSGENIC MOUSE; VACCINIA VIRUS; VIRUS CELL INTERACTION; ANIMAL; C57BL MOUSE; CELLULAR IMMUNITY; CULTURE TECHNIQUE; DIMERIZATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LISTERIOSIS; METABOLISM; T LYMPHOCYTE; VACCINIA;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; LISTERIA MONOCYTOGENES; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; VACCINIA VIRUS;

ANIMALS; CELL CULTURE TECHNIQUES; CYTOMEGALOVIRUS; DIMERIZATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LISTERIA MONOCYTOGENES; LISTERIOSIS; MICE; MICE, INBRED C57BL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; T-LYMPHOCYTES; VACCINIA;

EID: 78649973152     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015184     Document Type: Article

References (53)

1. Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23: 225-274.
2. Lanier LL (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9: 495-502.
3. Raulet DH (2003) Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3: 781-790.
4. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, et al. (2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7: 517-523.
5. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, et al. (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 99: 8826-8831.
6. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
7. Karre K, Ljunggren HG, Piontek G, Kiessling R (1986) Selective rejection of H- 2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675-678.
8. Orr MT, Lanier LL (2010) Inhibitory Ly49 receptors on mouse Natural Killer cells. Curr Top Microbiol Immunol: in press.
9. Carretero M, Cantoni C, Bellon T, Bottino C, Biassoni R, et al. (1997) The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol 27: 563-567.
10. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH (1996) Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 157: 4741-4745.
11. Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, et al. (1996) CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 5: 163-172.
12. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, et al. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799.
13. Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH (1998) Mouse CD94/ NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med 188: 1841-1848.
14. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 187: 813-818.
15. Lee N, Goodlett DR, Ishitani A, Marquardt H, Geraghty DE (1998) HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 160: 4951-4960.
16. Lanier LL, Corliss B, Wu J, Phillips JH (1998) Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8: 693-701.
17. Vance RE, Jamieson AM, Raulet DH (1999) Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/ NKG2E on mouse natural killer cells. J Exp Med 190: 1801-1812.
18. Berg SF, Dissen E, Westgaard IH, Fossum S (1998) Two genes in the rat homologous to human NKG2. Eur J Immunol 28: 444-450.
19. Houchins JP, Yabe T, McSherry C, Bach FH (1991) DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 173: 1017-1020.
20. Brooks AG, Posch PE, Scorzelli CJ, Borrego F, Coligan JE (1997) NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J Exp Med 185: 795-800.
21. Houchins JP, Lanier LL, Niemi EC, Phillips JH, Ryan JC (1997) Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol 158: 3603-3609.
22. Kaiser BK, Barahmand-Pour F, Paulsene W, Medley S, Geraghty DE, et al. (2005) Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. J Immunol 174: 2878-2884.
23. Vales-Gomez M, Reyburn HT, Erskine RA, Lopez-Botet M, Strominger JL (1999) Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLAE. EMBO J 18: 4250-4260.
24. Vance RE, Jamieson AM, Cado D, Raulet DH (2002) Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Proc Natl Acad Sci U S A 99: 868-873.
25. Vance RE, Tanamachi DM, Hanke T, Raulet DH (1997) Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur J Immunol 27: 3236-3241.
26. Ho EL, Heusel JW, Brown MG, Matsumoto K, Scalzo AA, et al. (1998) Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells. Proc Natl Acad Sci U S A 95: 6320-6325.
27. Makrigiannis AP, Pau AT, Schwartzberg PL, McVicar DW, Beck TW, et al. (2002) A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics 79: 437-444.
28. Kim S, Iizuka K, Kang HS, Dokun A, French AR, et al. (2002) In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 3: 523-528.
29. Hayakawa Y, Smyth MJ (2006) NKG2D and cytotoxic effector function in tumor immune surveillance. Semin Immunol 18: 176-185.
30. Brodin P, Lakshmikanth T, Johansson S, Karre K, Hoglund P (2009) The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 113: 2434-2441.
31. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, et al. (2005) A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
32. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
33. Joncker NT, Fernandez NC, Treiner E, Vivier E, Raulet DH (2009) NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J Immunol 182: 4572-4580.
34. Bix M, Liao NS, Zijlstra M, Loring J, Jaenisch R, et al. (1991) Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 349: 329-331.
35. Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D (1991) MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253: 199-202.
36. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, et al. (2001) Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2: 951-956.
37. Lodoen MB, Lanier LL (2006) Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 18: 391-398.
38. Kubota A, Kubota S, Lohwasser S, Mager DL, Takei F (1999) Diversity of NK cell receptor repertoire in adult and neonatal mice. J Immunol 163: 212-216.
39. Van Beneden K, Stevenaert F, De Creus A, Debacker V, De Boever J, et al. (2001) Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells. J Immunol 166: 4302-4311.
40. Sivakumar PV, Gunturi A, Salcedo M, Schatzle JD, Lai WC, et al. (1999) Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development. J Immunol 162: 6976-6980.
41. Yu J, Wei M, Mao H, Zhang J, Hughes T, et al. (2009) CD94 defines phenotypically and functionally distinct mouse NK cell subsets. J Immunol 183: 4968-4974.
42. Hanke T, Takizawa H, McMahon CW, Busch DH, Pamer EG, et al. (1999) Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11: 67-77.
43. Makrigiannis AP, Pau AT, Saleh A, Winkler-Pickett R, Ortaldo JR, et al. (2001) Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J Immunol 166: 5034-5043.
44. Petrie EJ, Clements CS, Lin J, Sullivan LC, Johnson D, et al. (2008) CD94- NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med 205: 725-735.
45. Sullivan LC, Clements CS, Beddoe T, Johnson D, Hoare HL, et al. (2007) The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition. Immunity 27: 900-911.
46. Kaiser BK, Pizarro JC, Kerns J, Strong RK (2008) Structural basis for NKG2A/ CD94 recognition of HLA-E. Proc Natl Acad Sci U S A 105: 6696-6701.
47. Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, et al. (1995) Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 25: 2433-2437.
48. Guma M, Cabrera C, Erkizia I, Bofill M, Clotet B, et al. (2006) Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis 194: 38-41.
49. Guma M, Budt M, Saez A, Brckalo T, Hengel H, et al. (2006) Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107: 3624-3631.
50. Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, et al. (2004) Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104: 3664-3671.
51. Cavanaugh VJ, Raulet DH, Campbell AE (2007) Upregulation of CD94/ NKG2A receptors and Qa-1b ligand during murine cytomegalovirus infection of salivary glands. J Gen Virol 88: 1440-1445.
52. Moser JM, Gibbs J, Jensen PE, Lukacher AE (2002) CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat Immunol 3: 189-195.
53. Rodriguez A, Carretero M, Glienke J, Bellon T, Ramirez A, et al. (1998) Structure of the human CD94 C-type lectin gene. Immunogenetics 47: 305-309.